Press Releases
-
CD ComputaBio Introduces PyMOL Software for Bioinformatics Analysis
-
Pronalyse’s Fusion Protein Characterization Service Aids in the Drug Development Process
-
Creative Proteomics Lipidomics Launches Ceramides Analysis Service
-
Creative Proteomics Metabolomics Unveils Drug-Resistant Metabolomics Research Service
-
Dolomite Bio launches RNAdia 2.0 Reagent Kit – Fast, Easy, Robust
Dolomite Bio has announced the launch of the RNAdia 2.0 reagent kit for single cell research. At a significantly lower cost compared to competitor reagents the new and improved RNAdia 2.0 kit alleviates that stress, allowing researchers to focus on what is important, doing more and discovering more.
Nov 29, 2022
-
UK Supplier expands to provide Chemically Defined & Serum-Free Cell Media Solutions for the Cell and Gene Therapy Industry
BioPharma Dynamics has announced the expansion of its extensive portfolio to offer a range of chemically defined T-Cell Media, DMSO-Free Cryopreservation Solutions, and Recombinant Growth Factors, for the Cell & Gene Therapy market.
Nov 29, 2022
-
Biopharma PEG Develops PEG Products For Click Chemistry
-
Huateng Pharma Supplies Semaglutide Intermediates Against Type 2 Diabetes
-
Genezen appoints Chief Commercial Officer to Executive Leadership Team
Genezen appoints Jeff Whitmore as CCO
Nov 28, 2022
-
Andelyn Biosciences to Manufacture First Gene Therapy for Infantile Neuroaxonal Dystrophy in the US
-
Creative Enzymes Expands Its Service Offering with the Launch of Custom Enzyme Blends
-
Creative Enzymes Provides DNA Molecular Weight Markers and Ladders
-
CD Genomics Expands Its Sequencing Portfolio with the Launch of Whole Exome Sequencing
-
MicrobioSeq Boosts Scientific Research with Gene Expression Analysis
-
Micro-Sphere Launches New Research & Development Services at Swiss Site
Global contract development and manufacturing organisation (CDMO) Micro-Sphere has launched a new, 200 square-foot research and development (R&D) lab to strengthen its services in formulation development and inhalation.
Nov 27, 2022
-
Zebrafish Disease Model: Developed by Creative Biogene to Support Multiple Therapeutic Areas
-
IntegrateRNA Develops Premade Circular RNA Products to Satisfy Various Downstream Applications
-
Microbiosci Develops Data-independent Acquisition Proteomics to Support Molecular Diagnostics
-
Creative Bioarray Develops More Than 1000 Cell Types Together with Selective Cell Culture Media
-
Creative Bioarray Releases GMP Grade Cytokines to Support Cell Manufacturing and Cell-based Therapies